Scott J Genshaft1, Robert D Suh2, Fereidoun Abtin3, Mark O Baerlocher4, Sean R Dariushnia5, A Michael Devane6, Elizabeth Himes7, Aaron Lisberg8, Siddharth Padia9, Sheena Patel7, Jane Yanagawa10. 1. Department of Radiologic Sciences, David Geffen School of Medicine at University of California, Los Angeles, California. Electronic address: SGenshaft@mednet.ucla.edu. 2. Department of Radiology, David Geffen School of Medicine at University of California, Los Angeles, Ronald Reagan UCLA Medical Center, Los Angeles, California. 3. Department of Radiology, Thoracic and Interventional Section, David Geffen School of Medicine at University of California, Los Angeles. 4. Department of Radiology, Royal Victoria Hospital, Ontario, Canada. 5. Department of Radiology and Imaging Sciences, Division of Interventional Radiology and Image-Guided Medicine, Emory University School of Medicine, Atlanta, Georgia. 6. Department of Radiology, Prisma Health, University of South Carolina School of Medicine Greenville, Greenville, South Carolina. 7. Society of Interventional Radiology, Fairfax, Virginia. 8. Department of Medicine, David Geffen School of Medicine at University of California, Los Angeles, California. 9. Department of Radiology, Section of Interventional Radiology, David Geffen School of Medicine at University of California, Los Angeles, California. 10. Division of Thoracic Surgery, David Geffen School of Medicine at University of California, Los Angeles, California.
Abstract
PURPOSE: To provide guidance on quality improvement thresholds for outcomes and complications of image-guided thermal ablation for the treatment of early stage non-small cell lung cancer, recurrent lung cancer, and metastatic disease. MATERIALS AND METHODS: A multidisciplinary writing group conducted a comprehensive literature search to identify studies on the topic of interest. Data were extracted from relevant studies and thresholds were derived from a calculation of 2 standard deviations from the weighted mean of each outcome. A modified Delphi technique was used to achieve consensus agreement on the thresholds. RESULTS: Data from 29 studies, including systematic reviews and meta-analyses, retrospective cohort studies, and single-arm trials were extracted for calculation of the thresholds. The expert writing group agreed on thresholds for local control, overall survival and adverse events associated with image-guided thermal ablation. CONCLUSION: SIR recommends utilizing the indicator thresholds to review and assess the efficacy of ongoing quality improvement programs. When performance falls above or below specific thresholds, consideration of a review of policies and procedures to assess for potential causes, and to implement changes in practices, may be warranted.
PURPOSE: To provide guidance on quality improvement thresholds for outcomes and complications of image-guided thermal ablation for the treatment of early stage non-small cell lung cancer, recurrent lung cancer, and metastatic disease. MATERIALS AND METHODS: A multidisciplinary writing group conducted a comprehensive literature search to identify studies on the topic of interest. Data were extracted from relevant studies and thresholds were derived from a calculation of 2 standard deviations from the weighted mean of each outcome. A modified Delphi technique was used to achieve consensus agreement on the thresholds. RESULTS: Data from 29 studies, including systematic reviews and meta-analyses, retrospective cohort studies, and single-arm trials were extracted for calculation of the thresholds. The expert writing group agreed on thresholds for local control, overall survival and adverse events associated with image-guided thermal ablation. CONCLUSION: SIR recommends utilizing the indicator thresholds to review and assess the efficacy of ongoing quality improvement programs. When performance falls above or below specific thresholds, consideration of a review of policies and procedures to assess for potential causes, and to implement changes in practices, may be warranted.